Harvard Business Review

JUNE 16, 2016

In July 2015, Novartis launched its new heart failure drug, Entresto, which Forbes in 2014 predicted would be a blockbuster — with expected sales of $10 billion annually — as the potential market in the US exceeds 5 million people with a heart failure condition. Laura Schneider for HBR. The failures continue.

Planning 8

Planning Competitive Intelligence Pharmaceuticals Brand 8

Harvard Business Review

FEBRUARY 16, 2016

In response to our survey in late 2015, they told us that on economic matters, uncertainty abounds. Results are based on all submissions as of December 1, 2015. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g.,

Politics 8

Politics Telecommunications Policies Biotechnology 8

Harvard Business Review

AUGUST 17, 2015

Cuba’s growth domestic product per capita in 2015 is approximately what it was in 1985. It could be an ideal location for healthcare organizations, but also for those in applied sciences, biotechnology, and pharmaceuticals. pharmaceutical company could be a great asset in the future. Have the doors opened to U.S.

Biotechnology 8

Biotechnology Tourism Human Capital Pharmaceuticals 8

Harvard Business Review

DECEMBER 29, 2015

Today, the International Diabetes Federation (IDF) estimates that 415 million people, or about one in every 11, are living with the condition; in 2015, 28 million more adults have it than in 2014. Make health a priority in urban planning.

Health Care 8

Health Care NGO Pharmaceuticals Globalization 8

Harvard Business Review

JANUARY 5, 2018

But over and over again in our three decades of experience as talent development and retention specialists, we’ve seen that companies consistently overlook half of them. These are jobs in R&D, technology, and other areas vital to a firm’s strategic direction, product development, and process efficiency.

McKinsey 8

McKinsey Human Resources Reputation Brand 8

Harvard Business Review

MAY 5, 2016

Within weeks there was $50 billion in business deals involving foreign companies, including the Airbus agreement (worth $25 billion) to sell 118 planes, and Italy’s state rail company’s $5 billion pact to develop the local rail network. However, remaining U.S. sanctions are delaying these projects being financed.

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

OCTOBER 26, 2015

A recent USA Today piece noted: “At the end of June [2015], there were 3,739 breweries in the U.S…that’s Or pharmaceuticals, although even in drug manufacturing trends toward personalized medicine make the current hegemony likely to be short-lived. At that rate, the number of U.S.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Strategy Driven

OCTOBER 10, 2016

As reaffirmed in Gartner’s 2015 report, How to Get Your Customer Service Employees to Care About the Customer , research shows “high levels of employee engagement contribute to higher levels of customer satisfaction.” What’s next? The spotlight on customer service recognition during these five days shouldn’t just be a moment in time.

Strategy 50

Strategy Pharmaceuticals Learning-by-Doing Outsourcing 50

Harvard Business Review

SEPTEMBER 4, 2015

However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. We found that, for pharmaceutical industry CEOs, there is a statistically significant relationship between a CEO’s specialist background and the firm’s performance.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

OCTOBER 27, 2015

At UCB, a medium-sized pharmaceutical company headquartered in Belgium, Heresh Rezavandi and his managers Michelle Maddix-Sovero are leading a young strategic intelligence function that’s part of the strategic marketing practice. There are, of course, exceptions — and other companies can learn from them.

Marketing 8

Marketing Competitive Intelligence Porter How To 8

Harvard Business Review

JUNE 24, 2015

In this adaptation from the new book, Your Strategy Needs a Strategy (HBR Press, 2015), BCG strategy experts make sense of the all the different, and competing, approaches to strategy: Which strategy is right for your business? When and how should you implement it?

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Harvard Business Review

JULY 6, 2016

For 78-year-old Tony, 3,4 DAP — which can be obtained at low cost from compounding pharmacies or for free through a compassionate-use program supported by a small privately held company, Jacobus Pharmaceuticals — is a lifesaver. Pharmaceutical companies traditionally invest heavily in research and development.

Price 15

Price Pharmaceuticals Company Health Care 15

Harvard Business Review

APRIL 6, 2017

I help the University of Utah hospital system manage its drug budgets and medication use policies, and in 2015 I got sticker shock. The 1984 Drug Price Competition and Patent Term Restoration Act gave pharmaceutical companies exclusive protections for innovating a new drug. Problems with generic drug makers. Ways to Fix the System.

System 13

System Pharmaceuticals Company Sample 13

Harvard Business Review

MAY 25, 2017

From 2015 to 2016, investors poured more than $8 billion into funding these tools. As adoption increases, companies that today provide therapeutics — principally pharmaceutical and medical device manufacturers — will begin to add digital health solutions to their portfolios.

Health Care 9

Health Care Trends Venture Funding Technology 9

Harvard Business Review

AUGUST 23, 2016

Republicans generally favor developing a pipeline of diverse candidates through director advocacy and mentorship, while Democrats are more likely to favor requiring that every director slate include diverse candidates, or that boards implement targets for diverse membership. chemicals, metals & mining, paper & forest products).

Politics 8

Politics Committee Telecommunications Diversity 8